Premium Nahrungsergänzungsmittel | artgerecht

Precision Medicine in Infectious Diseases

Precision medicine in infectious diseases uses genetic and molecular data to tailor diagnosis and treatment to each patient. This makes therapies more targeted and effective.

Regular tips about health Regular tips about health

Things worth knowing about "Precision medicine in infectious diseases"

Precision medicine in infectious diseases uses genetic and molecular data to tailor diagnosis and treatment to each patient. This makes therapies more targeted and effective.

What is Precision Medicine in Infectious Diseases?

Precision medicine in infectious diseases is a modern medical approach that aligns diagnostic and therapeutic strategies with the individual biological characteristics of a patient as well as the specific properties of the causative pathogen. Rather than applying a one-size-fits-all therapy, it leverages genetic, genomic, and molecular data to identify the most effective treatment for each individual patient.

This approach is gaining increasing importance in modern infectious disease medicine, particularly in the context of rising antimicrobial resistance, complex viral infections, and the need for more efficient therapies.

Core Principles of Precision Medicine in Infectious Diseases

Precision medicine in this field is built on several scientific pillars:

Pathogen genomics: Complete sequencing of a pathogen's genome (e.g. bacteria, viruses, fungi) allows precise identification of resistance genes, virulence factors, and transmission pathways.
Host genomics: Genetic variants in the human genome (e.g. polymorphisms in immune receptor genes) influence how a person responds to an infection and which medications are most effective.
Metagenomics: Analysis of all genetic material present in a clinical sample (e.g. blood, cerebrospinal fluid) allows simultaneous identification of multiple pathogens without prior culture.
Biomarker-based diagnostics: Specific molecular markers in blood or tissue help assess the severity of an infection and monitor treatment response.

Areas of Application

HIV and Antiretroviral Therapy

In the treatment of HIV, precision medicine is already well established. Before initiating antiretroviral therapy, the viral genome is analyzed for resistance mutations. Additionally, patients are tested for HLA-B*57:01 status to prevent severe hypersensitivity reactions to the drug abacavir.

Tuberculosis

In the management of tuberculosis, genome sequencing of Mycobacterium tuberculosis enables rapid detection of resistance to first- and second-line antibiotics, significantly shortening the time to effective therapy.

Viral Hepatitis

In hepatitis C, the genotype of the virus determines the optimal treatment regimen using direct-acting antiviral agents (DAAs). Targeted genotyping enables cure rates of over 95%.

Sepsis

In life-threatening sepsis, the use of molecular biomarkers (e.g. procalcitonin, interleukin-6) and genomic expression profiles allows early differentiation between bacterial and viral causes, enabling prompt and targeted treatment initiation.

Diagnostic Methods

Various advanced diagnostic techniques are used to implement precision medicine in infectious diseases:

Next-Generation Sequencing (NGS): High-throughput sequencing technology for rapid and comprehensive pathogen analysis.
Whole Genome Sequencing (WGS): Complete genomic analysis of pathogens for resistance profiling and outbreak investigation.
Multiplex PCR: Simultaneous detection of multiple pathogens in a single sample.
Proteomics and metabolomics: Analysis of proteins and metabolites to assess the host immune response.

Benefits and Challenges

Benefits

More targeted and effective therapies through individualized treatment
Reduction of unnecessary antibiotic use, thereby combating antimicrobial resistance
Earlier and more accurate identification of pathogens
Better prediction of disease course and treatment response

Challenges

High costs of genomic analyses and required infrastructure
Data privacy and ethical concerns surrounding the processing of genetic data
Lack of standardization and regulatory frameworks
Limited access in low- and middle-income countries

Future Perspectives

Precision medicine in infectious diseases is advancing rapidly. Artificial intelligence and machine learning are increasingly being applied to analyze large genomic and clinical datasets and to support treatment decisions. The goal is to treat infectious diseases faster, more precisely, and with fewer side effects.

References

Langelier C, Kalantar KL, Moberley S et al. - Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults. Proceedings of the National Academy of Sciences (2018).
World Health Organization (WHO) - Antimicrobial Resistance: Global Report on Surveillance (2023). Available at: https://www.who.int/publications/i/item/9789241564748
Goodwin S, McPherson JD, McCombie WR - Coming of age: ten years of next-generation sequencing technologies. Nature Reviews Genetics, 17(6):333-351 (2016).

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category